Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open‐label, Australian study

Disney, Alex; DE JERSEY, PETER; Kirkland, G; Mantha, Murty; A. Charlesworth, J.; Gallagher, Martin; C.H. Harris, David; Gock, Hilton; Mangos, George; MacMillan, Jamie; Liu, Wei; VISWALINGAM, AJIT

doi:10.1111/j.1440-1797.2006.00757.x

Public

Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open‐label, Australian study

Published in Nephrology • Feb 1, 2007

Authors:

Alex Disney

PETER DE JERSEY

G Kirkland

Abstract

AIM: Darbepoetin alfa, an erythropoiesis-stimulating protein, has a longer serum half-life than recombinant human erythropoietin, allowing less-frequent administration. This study aimed to demonstrate that once-monthly (QM) darbepoetin alfa administration would maintain haemoglobin (Hb) concentratio...

Subject

Darbepoetin alfa

Medicine

Dosing

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!